Items of Analysis | Standard of Analysis | Test Results |
Appearance | Dark red crystalline powder | Conform |
Identification | UV, TLC | Conform |
Loss on drying | 8.0%-12.0% | 8.4% |
Related substances | ≤5.0% | 1% |
Acetone | ≤5000ppm | 75ppm |
Total aerobic bacteria | ≤1000cfu/g | 10cfu/g |
Moulds and total yeasts | ≤100cfu/g | <10cfu/g |
Assay | 96.0%~102.0% | 98.3% |
Conclusion | Conforms to EP10.0 Standard |
We are professional hydroxocobalamin hydrochloride manufacturer and HYDROXOCOBALAMINE HYDROCHLORIDE supplier in China, We offer quality HYDROXOCOBALAMINE HYDROCHLORIDE you can fully trust, also we have India factory and producer of hydroxocobalamin hydrochloride,Pls send inquiry of HYDROXOCOBALAMINE HYDROCHLORIDE CAS:58288-50-9 to info@nbinno.com if you have any interests, thank you!
Related News: For example, by using molecular modeling tools to achieve rapid de novo design of new enzymes, it may be possible to increase activity, enhance temperature stability, or improve solvent compatibility to better align with the process in question. 4-hydroxy-3-naphthalen-1-ylchromen-2-one manufacturer Grégoire Boutonnet, Chief Operating Officer of NOVA, said: “I am thrilled to be joining the NOVA team at this exciting period of growth as we launch the Jinkō platform towards wider adoption in the clinical trial development space. (E)-5-((3R,5R,7aS)-3-Phenyl-hexahydro-pyrrolo[2,1-b]oxazol-5-yl)-pent-3-en-2-one supplier Problem is, China is currently focused on reining in healthcare expenditures and might not respond favorably to pricey rare disease meds. Glucose-1-phosphate adenylyltransferase (Clostridium perfringensstrain 13 gene glgC) manufacturer AZ’s chief financial officer and incoming Alexion head Marc Dunoyer acknowledged that the reimbursement infrastructure for rare disease drugs in China isn’t as advanced as it is in many developed economies. The rare disease market in China is still small, but there’s a growing recognition of its importance from authorities, he added.